Autoantibodies against BAFF have been described in healthy controls (HCs), but elevated levels in systemic lupus erythematosus (SLE) patients may contribute to autoimmune processes by regulating the availability and activity of BAFF [11,12]. The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.